Holland & Knight Advises Cencora in Sale of U.S. Consulting Services Operations to CareMetx
PHILADELPHIA (April 27, 2026) – Holland & Knight served as legal advisor to Cencora Inc. in connection with the sale of its U.S.-based Hub consulting services operations, previously conducted under the Lash Group brand and including TheraCom free goods pharmacy, to CareMetx LLC, a leading technology-enabled patient services provider headquartered in Bethesda, Maryland. The deal was announced on April 27.
The transaction encompasses Cencora's full-service Hub operations, patient access staffing infrastructure and free goods pharmacy fulfillment capabilities. The acquisition significantly expands CareMetx's end-to-end platform and strengthens its position as one of the most comprehensive patient access solutions providers in the specialty therapy market.
Headquartered in Conshohocken, Pennsylvania, Cencora is a global pharmaceutical company centered on improving the lives of people and animals around the world. Following the transaction, Cencora will continue to rely on CareMetx as a preferred partner for patient services in the United States.
Holland & Knight Partner Colby Smith and Associate Leah Simon (M&A) led the Firm's representation of Cencora. They were assisted by Partner Eric Rubin (Executive Compensation & Benefits) and Partners Jeff Mittleman and Andrew Namkung (Healthcare).
CareMetx was selected as the ideal partner to ensure a smooth transition for the patients, providers and clients currently served by Cencora's U.S. consulting services business.
More information on the transaction can be found here.
Recently recognized as the Private Equity Law Firm of the Year by the Global M&A Network and M&A Law Firm of the Year by M&A Advisor, Holland & Knight regularly ranks among the leading M&A and private equity law firms in reputable, benchmarking league tables published by Bloomberg, LSEG, Mergermarket, PitchBook and The Deal. Through the HK Deal Flow℠ program, Holland & Knight facilitates deal leads for clients and prospective clients by matching acquisition or capital raising opportunities with buyers and investors.